Morning Briefing
Summaries of health policy coverage from major news organizations
Mpox Vaccine Proves Highly Successful; Resistance To Cefiderocol Is Increasing
A new international study has shown mpox (formerly known as monkeypox) infections to be less severe among those who are vaccinated or had a previous infection in 2022, underlining the importance and effectiveness of vaccination. (Queen Mary University of London, 9/5)
A systematic review and meta-analysis found resistance to cefiderocol was low overall but "alarmingly high" among certain types of carbapenem-resistant bacteria, Greek researchers reported late last week in Clinical Microbiology and Infection. (Dall, 9/5)
A study conducted within a university health system found a greater proportion of inappropriate antibiotic prescribing for respiratory conditions during the winter months, researchers reported today in Antimicrobial Stewardship & Healthcare Epidemiology. (Dall, 9/5)
Scientists have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to it. (Queen Mary University of London, 9/4)
